Intelligence Platform
Patents
Browse 3,494 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 10543221
Beta-lactamase inhibitors, formulations, and uses thereof
granted patentUS 10543280
Stabilization of biomolecules using sugar polymers
granted patentUS 10543283
Intranasal administration of guanidinylated aminoglycosides
granted patentUS 10537528
Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine compounds
granted patentUS 10537529
Cell-free methods of producing vault particles and vault particles resulting therefrom
granted patentUS 10537535
Histone deacetylase inhibitors
granted patentUS 10533190
Methods and compositions for RNA-directed target DNA modification and for RNA-directed mod
granted patentUS 10533056
Macropinocytosing human anti-CD46 antibodies and targeted cancer therapeutics
granted patentUS 10526359
Thiosaccharide mucolytic agents
granted patentUS 10526619
Methods and compositions for RNA-directed target DNA modification and for RNA-directed mod
granted patentUS 10517942
Polypeptide glycopeptide fragments from the V1/V2 and V3 domains of the HIV-1 envelope pro
granted patentUS 10518074
Compositions comprising nanostructures for cell, tissue and artificial organ growth, and m
granted patentUS 10517898
Compositions and methods related to hematologic recovery
granted patentUS 10519467
Methods and compositions for RNA-directed target DNA modification and for RNA-directed mod
granted patentUS 10517491
Cardiac phase-resolved non-breath-hold 3-dimensional magnetic resonance angiography
granted patentUS 10520499
Methods of diagnosing and treating autism
granted patentUS 10513712
Methods and compositions for RNA-directed target DNA modification and for RNA-directed mod
granted patentUS 10512630
Compositions and methods for treating cancer
granted patentUS 10512669
Blockade of inflammatory proteases with cyclic peptides
granted patentUS 10507239
V1/V2 fragments of a HIV-1 envelope glycoprotein
granted patentUS 10507284
Daily periodic target-zone modulation in the model predictive control problem for artifici
granted patentUS 10501816
Compositions and methods for detecting human pegivirus 2 (HPgV-2)
granted patentUS 10500271
Compositions and methods for self-adjuvanting vaccines against microbes and tumors
granted patentUS 10500177
Glutarate compounds for treating ischemia-reperfusion injuries
granted